Origin Sciences

Private

United KingdomHealthcare & Life Scienceshttps://www.originsciences.com/

Last Round

VC Round

Oct 21, 2014

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Origin Sciences is a medical technology company that develops diagnostic devices and tests for the detection and monitoring of gastrointestinal diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

gastrointestinal diagnosticsrectal mucus collectioncolorectal cancer screeningliquid biopsymedical devicegenomics laboratory servicesinflammatory bowel diseaseIBDmolecular analysisbioinformaticsnon-invasive diagnosticsprecision medicineclinical diagnosticsmulti-omics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Origin Sciences Comparables

Compare Origin Sciences with similar companies based on industry and business-model similarity.

Origin Sciences comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Geneoscopy	74%
Cyted Health	72%
Guardant Health	61%

View all Comparables

Origin Sciences Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Oct 21, 2014

View all Funding Rounds

Key People

Founding team and executive leadership

Hugo Lywood

Chief Executive Officer

Executive Team

Andrew Page

Chief Technology Officer

Executive Team

Shane Hall

Chief Financial Officer

Executive Team

Jamie Yexley

Chief Operating Officer

Executive Team

View all key people

Origin Sciences Investors

Notable investors and investment history

Origin Sciences investors
Investor	Rounds
CSVE Ventures	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 19, 2026
Monthly visitors increased 777% MoM.
Sep 6, 2025
Grew 21% QoQ, from 24 to 29 employees.

View all signals

Origin Sciences Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Origin Sciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Origin Sciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersUnited Kingdom

Employee Range35

Year Founded2003

Last FundingOct 21, 2014

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.